MALAT1 and depressive symptom measurement: There is growing interest in HCN channel activity for its role in axonal (49) and dendritic (50) signaling, and for its roles in epilepsy (51), depression (52), neurodevelopmental disorders (53, 54), and neurodegenerative disease (55).